Available drugs and promising agents under investigation.
D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003596:Cytosine / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D009761:Nystatin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use; D011193:Potassium Iodide / Q000627:therapeutic use; D013266:Stilbamidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D010455:Peptides; D013266:Stilbamidines; D013449:Sulfonamides; D009761:Nystatin; D011193:Potassium Iodide; D005461:Fluorine; D006118:Griseofulvin; D000666:Amphotericin B; D003596:Cytosine; D010400:Penicillin G